Posted by yxibow on September 20, 2008, at 0:53:04
In reply to Re: New meds to come?, posted by JayBTV2 on September 16, 2008, at 13:36:04
> Agomelatine (Valdoxan) is the best hope we have coming down the pike. Hopefully will be available next year in Europe and if so hopefully in the US by 2010.
>
> It's a novel antidepressant which works on the Melatonin receptors as long as slightly w/ Serotonin.
>
> Latest study w/ Valdoxan:
>
> http://www.pslgroup.com/dg/22a766.htm
>This would be interesting but Servier largely is bypassed in the US. They mainly have a profile of agents approved in France and EMEA. I don't know if its politics or a lack of rechallenging FDA findings.
poster:yxibow
thread:851906
URL: http://www.dr-bob.org/babble/20080915/msgs/853038.html